WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KYMR

Based on 6 analysts offering 12 month price targets for Kymera Therapeutics Inc.
Min Forecast
$37.00+141.36%
Avg Forecast
$49.83+225.07%
Max Forecast
$85.00+454.47%

Should I buy or sell KYMR stock?

Based on 6 analysts offering ratings for Kymera Therapeutics Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KYMR stock forecasts and price targets.

KYMR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 38%
63
HoldMaintains$37.00+141.36%2023-08-29
Stifel Nicolaus
Bottom 8%
8
Strong BuyMaintains$52.00+239.20%2023-08-07
Credit Suisse
Bottom 25%
25
HoldMaintains$37.00+141.36%2023-08-04
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$85.00+454.47%2023-08-04
Truist Securities
Bottom 6%
6
Strong BuyInitiates Coverage On$50.00+226.16%2023-06-30
Raymond James
Bottom 10%
10
BuyUpgrades$38.00+147.88%2023-05-05

1 of 1

Forecast return on equity

Is KYMR forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is KYMR forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

KYMR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KYMR$15.33$49.83+225.07%Buy
INVA$13.16$22.50+70.97%Strong Buy
PHVS$20.61$27.00+31.00%Strong Buy
VALN$12.06$22.00+82.42%Buy
INBX$19.86$31.00+56.09%Buy
View Top Biotech Stocks

Kymera Therapeutics Stock Forecast FAQ

Is Kymera Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: KYMR) stock is to Buy KYMR stock.

Out of 6 analysts, 2 (33.33%) are recommending KYMR as a Strong Buy, 2 (33.33%) are recommending KYMR as a Buy, 2 (33.33%) are recommending KYMR as a Hold, 0 (0%) are recommending KYMR as a Sell, and 0 (0%) are recommending KYMR as a Strong Sell.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.

What is KYMR's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: KYMR) forecast ROE is N/A, which is considered weak.

What is KYMR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year KYMR price target, the average KYMR price target is $49.83, with the highest KYMR stock price forecast at $85.00 and the lowest KYMR stock price forecast at $37.00.

On average, Wall Street analysts predict that Kymera Therapeutics's share price could reach $49.83 by Aug 29, 2024. The average Kymera Therapeutics stock price prediction forecasts a potential upside of 225.07% from the current KYMR share price of $15.33.

What is KYMR's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: KYMR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.